NEW YORK (GenomeWeb News) – Metabolomics company Molecular Biometrics said yesterday that it has completed a $12.5 million Series B financing.

New investor Atlas Ventures led the financing round with participation from existing investors Safeguard Scientifics and Oxford Bioscience Partners.

Based in Norwood, Mass., Molecular Biometrics will use the cash to accelerate the global launch of its lead product, ViaMetrics-E, a rapid, non-invasive procedure designed to enhance in vitro fertilization outcomes by using cellular metabolomic signatures.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

A federal grand jury has indicted Elizabeth Holmes and Ramesh Balwani for alleged wire fraud in conjunction with their activities at Theranos.

Nature News reports that some developers are nervous about GitHub's acquisition by Microsoft.

A direct-to-consumer genetic testing company sent out used spit kits, CNBC reports.

In PLOS this week: comparison of commercial bisulfite kits, new method to predict essential proteins, and more

Jul
19
Sponsored by
Thermo Fisher Scientific

This webinar will discuss how ultra-highly sensitive and customizable targeted next-generation sequencing panels are applied in inherited disease research.